CAN AFFECTIVE DISORDERS AND SCHIZOPHRENIA BE DIFFERENTIATED ON AN IMMUNOLOGICAL BASIS?

被引：0
|
作者：
Sperner-Unterweger, Barbara [1 ]
机构：
[1] Med Univ Innsbruck, Innsbruck, Austria
来源：
SCHIZOPHRENIA RESEARCH | 2012年 / 136卷
关键词：
D O I：
10.1016/S0920-9964(12)70170-6
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [1] AN IMMUNOLOGICAL BASIS OF SCHIZOPHRENIA AND AFFECTIVE-DISORDERS
    FONTANA, A
    STORCK, U
    ANGST, J
    DUBS, R
    ABEGG, A
    GROB, PJ
    [J]. NEUROPSYCHOBIOLOGY, 1980, 6 (05) : 284 - 289
  • [2] GENETIC AND IMMUNOLOGICAL FACTORS IN AFFECTIVE-DISORDERS AND SCHIZOPHRENIA
    MENDLEWICZ, J
    SEVY, S
    [J]. PROGRESS IN BRAIN RESEARCH, 1986, 65 : 1 - 15
  • [3] Neurotrophic factors in schizophrenia and affective disorders: Basis for novel therapeutic approaches?
    Ehrenreich, H
    [J]. EUROPEAN PSYCHIATRY, 2005, 20 : S50 - S51
  • [4] Olanzapine in Schizophrenia and Affective Disorders
    Undurraga, Juan
    Vieta, Eduard
    Tohen, Mauricio
    Colom, Francesc
    [J]. DRUG SAFETY, 2012, 35 (12) : 1185 - 1186
  • [5] Catatonia, schizophrenia, and affective disorders
    Chalasani, P.
    Healy, D.
    Karthikeya, K.
    Parlapalli, T.
    Morriss, R.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (07): : 897 - 898
  • [6] Genetics of schizophrenia and affective disorders
    Maier, W
    Zobel, A
    Rietschel, M
    [J]. PHARMACOPSYCHIATRY, 2003, 36 : S195 - S202
  • [7] Olanzapine in Schizophrenia and Affective Disorders
    Juan Undurraga
    Eduard Vieta
    Mauricio Tohen
    Francesc Colom
    [J]. Drug Safety, 2012, 35 : 1185 - 1186
  • [8] IMMUNOLOGICAL DISORDERS AS BASIS OF DISEASE
    DUNCAN, JR
    [J]. JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1976, 169 (10) : 1122 - 1122
  • [9] Neuroprotective agents in schizophrenia and affective disorders
    Krebs, Michael
    Leopold, Karolina
    Hinzpeter, Axel
    Schaefer, Martin
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (07) : 837 - 848
  • [10] Olanzapine in Schizophrenia and Affective Disorders Reply
    Stip, Emmanuel
    Moteshafi, Hoda
    [J]. DRUG SAFETY, 2012, 35 (12) : 1186 - 1186
12345